Physician profile
Andrew Yu
NPI 1881122471
$2,732.67
in general payments reported to CMS, 2019-2025
10 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $445 · 2024: $1,600 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,972 · Travel and Lodging: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,971.51 |
| Travel and Lodging | $761.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $761.16 | 2024 | Cerepak Uniform, Trufill, Cerenovus Enterprise |
| Imperative Care, INC | $524.45 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Stryker Corporation | $418.82 | 2024 | Evolve, Trevo |
| Boston Scientific Corporation | $374.00 | 2024-2025 | Exalt Model D, Overstitch Endoscopic Suturing System |
| Medtronic, INC. | $193.86 | 2023 | Solitaire X, Pipeline, Axium Primetm |
| Microvention, INC. | $161.49 | 2023-2025 | Tubing Kit - Stroke, Eric Retrieval Device, Web Aneurysm Embolization System |
| Astrazeneca Pharmaceuticals LP | $125.77 | 2023 | Saphnelo |
| Nevro Corp. | $74.94 | 2024 | Senza |
| Balt USA, LLC | $73.70 | 2024 | Optima Coil System, Prestige Coil System |
| Scientia Vascular | $24.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.